Expression of insulin-like growth factor-1 and insulin-like growth factor-1 receptors in EL4 lymphoma cells overexpressing growth hormone

Cellular Immunology

Volumn 234, Issue 1, 2005, Pages 54-66

  Weigent, Douglas A ^a   Arnold, Robyn E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Growth hormone; Insulin like growth factor 1; Insulin like growth factor 1 receptor; Lymphocytes

Indexed keywords

ANTIBODY; GROWTH HORMONE; IODINE 125; LUCIFERASE; NITRIC OXIDE; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL LINE; CELL PROTECTION; CONTROLLED STUDY; GENETIC TRANSFECTION; LYMPHOMA CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; VECTOR CONTROL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; APOPTOSIS; BINDING SITES; CELL LINE, TUMOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; LYMPHOMA; METHYL METHANESULFONATE; MICE; MUTATION; NITRIC OXIDE; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; RNA, MESSENGER;

EID: 23744490395     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.04.016     Document Type: Article

References (78)

1. D.A. Weigent, and J.E. Blalock Production of peptide hormones and neurotransmitters by the immune system J.E. Blalock Neuroimmunoendocrinology 1997 Karger Basel 1 30
2. N. Hattori, A. Shimatsu, M. Sugita, S. Kumagai, and H. Imura Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH Biochem. Biophys. Res. Commun. 168 1990 396 401
3. T.L. Kao, S.C. Supowit, E.A. Thompson, and W.J. Meyer III Immunoreactive growth hormone production by human lymphocyte cell lines Cell. Mol. Neurobiol. 12 1992 483 498
4. S. Varma, P. Sabharwal, J.F. Sheridan, and W.B. Malarkey Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay J. Clin. Endocrinol. Metab. 76 1993 49 53
5. D.A. Weigent, J.B. Baxter, W.E. Wear, L.R. Smith, K.L. Bost, and J.E. Blalock Production of immunoreactive growth hormone by mononuclear leukocytes FASEB J. 2 1988 2812 2818
6. D.A. Weigent Growth hormone and insulin-like growth factor-1 production by cells of the immune system L. Matera R. Rapaport Growth and lactogenic hormones 2002 Elsevier Science New York 87 100
7. E.L. Hooge-Peters, and R. Hooghe Growth hormone, prolactin and IGF-1 as lymphohemopoietic cytokines 1990 R.G. Landes Co Austin
8. S. Arkins, N. Rebeiz, A. Biragyn, D.L. Reese, and K.W. Kelley Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts Endocrinology 133 1993 2334 2343
9. M. Wynes, and D. Riches Induction of macrophage insulin-like growth factor-1 expression by the Th2 cytokines IL-4 and IL-13 J. Immunol. 171 2003 3550 3559
10. P.E. Clayton, R.N. Day, C.M. Silva, P. Hellmann, K.H. Day, and M.O. Thorner Growth hormone induces tyrosine phosphorylation but does not alter insulin-like growth factor-1 gene expression in human IM-9 lymphocytes J. Mol. Endocrinol. 13 1994 127 136
11. J.B. Baxter, J.E. Blalock, and D.A. Weigent Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone Endocrinology 129 1991 1727 1734
12. D.A. Weigent, J.B. Baxter, and J.E. Blalock The production of growth hormone and insulin-like growth factor- I by the same subpopulation of rat mononuclear leukocytes Brain Behav. Immun. 6 1992 365 376
13. M.E. Geffner, N. Bersch, B.M. Lippe, R.G. Rosenfeld, R.L. Hintz, and D.W. Golde Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-I J. Clin. Endocrinol. Metab. 71 1990 464 469
14. D.A. Weigent Immunoregulatory properties of growth hormone and prolactin J. Pharmacol Ther. 69 1996 237 257
15. R. Rosenfeld, A.V. Thorsson, and R.L. Hintz Increased somatomedin receptor sites in newborn circulating human mononuclear cells J. Clin. Endocrinol. Metab. 48 1979 456
16. E.W. Johnson, L.A. Jones, and R.W. Kozak Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes J. Immunol. 148 1992 63 71
17. R. Kooijman, M. Willems, C.J. De Haas, G.T. Rijkers, A.G. Schuurmans, S.C. Van Buul-Offers, C.J. Heijnen, and B.J. Zegers Expression of type 1 insulin-like growth factor receptors on human peripheral blood mononuclear cells Endocrine 131 1992 2244 2250
18. S. Verland, and S. Gammeltoft Functional receptors for insulin-like growth factors I and II in rat thymocytes and mouse thymoma cells Mol. Cell. Endocrinol. 67 1989 207 216
19. R.J. Cross, L.H. Elliott, L.A. Morford, T.L. Roszman, and J.P. McGillis Functional characterization of the insulin-like growth factor 1 receptor on Jurkat T cells Cell. Immunol. 160 1995 205 210
20. Y. Yang, A. Hoeflich, V. Kessler, B. Barenton, W. Blum, H. Schwarz, and W. Kiess Human IM-9 lymphoblasts as a model of the growth hormone-insulin-like growth factor axis: gene expression, and interactions of ligands with receptors and binding proteins Regul. Pept. 48 1993 41 53
21. M. Segretin, A. Galeano, A. Roldan, and R. Schillaci Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes Horm. Res. 59 2003 276 280
22. R. Baserga, A. Hongo, M. Rubini, M. Prisco, and B. Valentinis The IGF-1 receptor in cell growth, transformation, and apoptosis Biochim. Biophys. Acta Rev. Cancer 1332 1997 F105 F126
23. M. Shalita-Chesner, J. Katz, J. Shemer, and H. Werner Regulation of insulin-like growth factor-1 receptor gene expression by tumor necrosis factor-alpha and interferon-gamma Mol. Cell. Endocrinol. 176 2001 1 12
24. A.M. Vincent, and E.L. Feldman Control of cell-survival by IGF signalling pathways Growth Horm. IGF Res. 12 2002 193 197
25. R. O'Connor Regulation of IGF-1 receptor signaling in tumor cells Horm. Metab. Res. 35 2003 771 777
26. T.J. Merimee, M.B. Grant, C.M. Broder, and L.L. Cavalli-Sforza Insulin-like growth factor secretion by human B-lymphocytes: a comparison of cells from normal and pygmy subjects J. Clin. Endocrinol. Metab. 69 1989 978 984
27. S. Merchav, I. Tatarsky, and Z. Hochberg Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone J. Clin. Invest. 81 1988 791 797
28. V.F. Tapson, M. Boni-Schnetzler, P.F. Pilch, D.M. Center, and J.S. Berman Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro J. Clin. Invest. 82 1988 950 957
29. Y.K. Fu, S. Arkins, B.S. Wang, and K.W. Kelley A novel role of growth hormone and insulin-like growth factor: priming neutrophils for superoxide anion secretion J. Immunol. 146 1991 1602 1608
30. R. Clark The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function Endocr. Rev. 18 1997 157 179
31. M.G. Brocardo, R. Schillaci, A. Galeano, M. Radrizzani, V. White, A.G. Guerrico, T.A. Santa-Coloma, and A. Roldan Early effects of insulin-like growth factor-1 in activated human T lymphocytes J. Leukoc. Biol. 70 2001 297 305
32. S. Jeay, G.E. Sonenshein, M.C. Postel-Vinay, and E. Baixeras Growth hormone prevents apoptosis through activation of nuclear factor-kB in interleukin-3-dependent Ba/F3 cell line Mol. Endocrinol. 14 2000 650 661
33. S. Jeay, G.E. Sonenshein, P.A. Kelly, M.C. Postel-Vinay, and E. Baixeras Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kB and phosphatidylinositol 3-kinase Endocrinology 142 2001 147 156
34. E. Baixeras, S. Jeay, P.A. Kelly, and M.C. Postel-Vinay The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the pro-B Ba/F3 cell line Endocrinology 142 2001 2968 2977
35. J.A. Costoya, J. Finidori, S. Moutoussamy, R. Senaris, J. Devesa, and V.M. Arce Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway Endocrinology 140 1999 5937 5943
36. Q. Liu, D. Schacher, C. Hurth, G.G. Freund, R. Dantzer, and K.W. Kelley Activation of phosphoatidylinositol 3′-kinase by insulin-like growth factor-1, rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes J. Immunol. 159 1997 829
37. W. Tu, P.-T. Cheung, and Y.-L. Lau Insulin-like growth factor 1 promotes cord blood T cell maturation and inhibits its spontaneous and phytohemagglutinin-induced apoptosis through different mechanisms J. Immunol. 165 2000 1331 1336
38. R. Baserga, F. Peruzzi, and K. Reiss The IGF-1 receptor in cancer biology Int. J. Cancer 107 2003 873 877
39. R.E. Arnold, and D.A. Weigent The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone J. Neuroimmunol. 134 2003 82 94
40. R.E. Arnold, and D.A. Weigent The inhibition of apoptosis in EL4 lymphoma cells overexpressing growth hormone Neuroimmunomodulation 25 2004 159 177
41. Q.T. Rohlik, D. Adams Jr., F.C. Kull, and S. Jacobs An antibody to the receptor for insulin-like growth factor 1 inhibits the growth of MCF-7 cells in tissue culture Biochem. Biophys. Res. Commun. 149 1987 276 281
42. L. Wang, X. Wang, and M.L. Adamo Two putative GATA motifs in the proximal exon 1 promoter of the rat insulin-like growth factor I gene regulate basal promoter activity Endocrinology 141 2000 1118 1126
43. R.A. O'Connor, A. Kauffmann-Zeh, Y. Liu, S. Lehar, G.I. Evan, R. Baserga, and W.A. Blattler Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis Mol. Cell. Biol. 17 1997 427 435
44. H.B. Segard, S. Moulin, S. Boumard, C. Augier de Cremiers, P.A. Kelly, and J. Finidori Autocrine growth hormone production prevents apoptosis and inhibits differentiation in C2C12 myoblasts Cell. Signal. 15 2003 615 623
45. X. Zhang, T. Zhu, Y. Chen, H.C. Mertani, K.O. Lee, and P.E. Lobie Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene J. Biol. Chem. 278 2003 7580 7590
46. N. Liu, H.C. Mertani, G. Norstedt, J. Tornell, and P.E. Lobie Mode of the autocrine/paracrine mechanism of growth hormone action Exp. Cell Res. 237 1997 196 206
47. R.N. Re The origins of intracrine hormone action Am. J. Med. Sci. 323 2002 43 48
48. R.N. Re The nature of intracrine peptide hormone action Hypertension 34 1999 534 538
49. D. LeRoith, H. Werner, D. Beitner-Johnson, and C.T. Roberts Jr. Molecular and cellular aspects of the insulin-like growth factor1 receptor Endocr. Rev. 16 1995 143 163
50. G. Pandini, F. Frasca, M. Rossana, L. Sciacca, R. Vigneri, and A. Belfiore Insulin/insulin-like growth factor-1 hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved J. Biol. Chem. 277 2002 39684 39695
51. F.C. Kull, S. Jacobs, Y.F. Su, M.E. Svoboda, J.J. VanWyk, and P. Cuatrecasas Molecular antibody to receptor for insulin and somatomedin C J. Biol. Chem. 258 1983 6561 6566
52. G. Pandini, R. Vigneri, A. Costantino, F. Frasca, A. Ippolito, Y. Fujita-Yamaguchi, K. Siddle, I.D. Goldfine, and A. Belfiore Insulin and insulin-like growth factor-I (IGF-1) receptor overexpression in breast cancers leads to insulin/IGF-1 hybrid receptor overexpression: evidence for a second mechanism of IGF-1 signaling Clin. Cancer Res. 5 1999 1935 1944
53. D. Beitner-Johnson, H. Werner, C.T. Roberts Jr., and D. LeRoith Regulation of insulin-like growth factor 1 receptor gene expression by Sp1: physical and functional interactions of Sp1 at GC boxes and at a CT element Mol. Endocrinol. 9 1995 1147 1156
54. K.J. Scheidegger, J. Du, and P. Delafontaine Distinct and common pathways in the regulation of insulin-like growth factor-1 receptor gene expression by angiotensin II and basic fibroblast growth factor J. Biol. Chem. 274 1999 3522 3530
55. H. Werner, F.J. Rauscher III, V.P. Sukhatme, I.A. Drummond, C.T. Roberts Jr., and D. LeRoith Transcriptional repression of the insulin-like growth factor 1 receptor (IGF-1-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-1-R gene transcription start site J. Biol. Chem. 269 1994 12577 12582
56. H. Werner, B. Stannard, M.A. Bach, D. LeRoith, and C.T. Roberts Jr. Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor 1 (IGF-1) receptor gene Biochem. Biophys. Res. Commun. 169 1990 1021 1027
57. M. Rubini, H. Werner, E. Gandini, C.T. Roberts Jr., D. LeRoith, and R. Baserga Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene Exp. Cell Res. 211 1994 374 379
58. J. Woelfle, D.J. Chia, and P. Rotwein Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation J. Biol. Chem. 278 2003 51261 51266
59. H. Yoshizato, M. Tanaka, N. Nakai, N. Nakao, and K. Nakashima Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells Endocrinology 145 2004 214 220
60. T.J.J. Wood, D. Sliva, P.E. Lobie, F. Goullieux, A.L. Mui, B. Groner, G. Norstedt, and L.-A. Haldosen Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter Mol. Cell. Endocrinol. 130 1997 69 81
61. M. Prisco, A. Hongo, M.G. Rizzo, A. Sacchi, and R. Baserga The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal Mol. Cell. Biol. 17 1997 1084 1092
62. R. Baserga The contradictions of the insulin-like growth factor 1 receptor Oncogene 19 2000 5574 5581
63. F. Peruzzi, M. Prisco, M. Dews, P. Salomoni, E. Grassilli, G. Romano, B. Calabretta, and R. Baserga Multiple signalling pathways of the insulin-like growth factor I receptor in protection from apoptosis Mol. Cell. Biol. 19 1999 7203 7215
64. M. Parrizas, A.R. Saltiel, and D. LeRoith Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways J. Biol. Chem. 272 1997 154 161
65. C.S. Zong, J. Chang, D.E. Levy, C. Horvath, H.B. Sadowski, and L.H. Wang Mechanism of STAT3 activation by insulin-like growth factor I receptor J. Biol. Chem. 275 2000 15099 15105
66. J.B. Mannick, K. Asano, K. Izumi, E. Kieff, and J.S. Stamler Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation Cell 79 1994 1137 1146
67. A.M. Genaro, S. Hortelano, A. Alvarez, C. Martinez, and L. Bosca Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels J. Clin. Invest. 95 1995 1884 1890
68. H. Hebestreit, B. Dibbert, I. Balatti, D. Braun, A. Schpowal, K. Blaser, and H.U. Simon Disruption of fas receptor signalling by nitric oxide in eosinophils J. Exp. Med. 187 1998 415 425
69. L. Rossig, J. Haendeler, C. Hermann, P. Malchow, C. Urbich, A. Zeiher, and S. Dimmeler Nitric oxide downregulates MKP-3 mRNA levels. Involvement in endothelial cell protection from apoptosis J. Biol. Chem. 275 2000 25502 25507
70. Y.M. Kim, R.V. Talanian, and T.R. Billiar Nitric oxide inhibits apoptosis by preventing increases in caspase-3 activity via two distinct mechanisms J. Biol. Chem. 272 1997 25502 25507
71. F. Dodd, M. Limoges, R.T.M. Boudreau, P.R. Murphy, and C.K.L. Too l-arginine inhibits apoptosis via an NO-dependent mechanism in Nb2 lymphoma cells J. Cell. Biochem. 77 2000 624 634
72. H. Zhao, N. Dugas, C. Mathiot, A. Delmer, B. Dugas, F. Sigaux, and J.P. Kolb B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity Blood 92 1998 1031 1043
73. H.T. Chung, H.O. Pae, B.M. Choi, T.R. Billiar, and Y.M. Kim Nitric oxide as a bioregulator of apoptosis Biochem. Biophys. Res. Commun. 282 2001 1075 1079
74. J. Li, S. Yang, and T.R. Billiar Cyclic nucleotides suppress tumor necrosis factor alpha-mediated apoptosis by inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation J. Biol. Chem. 275 2000 13026 13034
75. D.D. Mosser, A.W. Caron, L. Bourget, C. Denis-Larose, and B. Massie Role of the human heat shock protein HSP70 in protection against stress-induced apoptosis Mol. Cell. Biol. 17 1997 5317 5327
76. B.J. Michell, J.E. Griffiths, K.I. Mitchellhill, I. Rodriguez-Crespo, T. Tiganis, S. Bozinovski, P.R. deMontellano, B.E. Kemp, and R.B. Pearson The Akt kinase signals directly to endothelial nitric oxide synthase Curr. Biol. 9 1999 845 848
77. P. Bernabei, M. Bosticardo, G. Losana, G. Regis, F. DiPaola, S. DeAngelis, M. Biovarelli, and F. Novelli IGF-1 down-regulates IFN-γ R2 chain surface expression and desensitizes IFN-γ/STAT-1 signalling in human T lymphocytes Blood 102 2003 2933 2939
78. R. Kooijman, S.C. Van Buul-Offers, L.E. Scholtens, H.J. Schuurman, L.J. van den Brande, and B.J. Zegers T cell development in insulin-like growth factor II transgenic mice J. Immunol. 154 1995 5736 5745